INTRATUMORAL INJECTION

Clinical trials for INTRATUMORAL INJECTION explained in plain language.

Never miss a new study

Get alerted when new INTRATUMORAL INJECTION trials appear

Sign up with your email to follow new studies for INTRATUMORAL INJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

New cancer injection seeks to boost radiation and immunotherapy power

Disease control Recruiting now

This early-stage study is testing a new drug called RiMO-301, which is injected directly into tumors. It is being combined with a short, intense course of radiation and standard immunotherapy drugs (pembrolizumab or nivolumab) for people with advanced head and neck cancer that ca…

Matched conditions: INTRATUMORAL INJECTION

Phase: PHASE1, PHASE2 • Sponsor: Coordination Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

INTRATUMORAL INJECTION

Get alerted when new INTRATUMORAL INJECTION trials appear

New cancer injection seeks to boost radiation and immunotherapy power